Skip Navigation

European Heart Journal 2003 24(1):21-23; doi:10.1016/S0195-668X(02)00693-0
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zijlstra, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zijlstra, F
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation

F Zijlstra

Department of Cardiology, Isala Klinieken, locatie Weezenlanden, Zwolle, The Netherlands

The first 10% of the full text of this article appears below.

See doi:10.1053/S0195-668X(02)00468-2for the article to which this editorial refers.

Primary angioplasty has been shown to besuperior to thrombolytic therapy for treatment of patients with acute ST segment elevation myocardial infarction in randomized trials.1–11 However, even in countries where large numbers of percutaneous coronary interventions are performed, thrombolytic therapy is still used far more often, in daily practice. This is caused by issues such as logistical difficulties, reimbursement, variability . . . [Full Text of this Article]

Angioplasty vs thrombolysis: a summary of the evidence

Angioplasty after interhospital transportation vs on-site thrombolysis: a summary of the evidence


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial—PRAGUE-2
P. Widimsky, T. Budesínsky, D. Vorác, L. Groch, M. Zelízko, M. Aschermann, M. Branny, J. St'ásek, P. Formánek, and on behalf of the ‘PRAGUE’ Study Group Investigators
EHJ 2003 24: 94-104. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
NEJMHome page
M. R. Le May, D. Y. So, R. Dionne, C. A. Glover, M. P.V. Froeschl, G. A. Wells, R. F. Davies, H. L. Sherrard, J. Maloney, J.-F. Marquis, et al.
A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction
N. Engl. J. Med., January 17, 2008; 358(3): 231 - 240.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. K. Jacobs, E. M. Antman, D. P. Faxon, T. Gregory, and P. Solis
Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Executive Summary
Circulation, July 10, 2007; 116(2): 217 - 230.
[Full Text] [PDF]


Home page
CirculationHome page
G. Ellrodt, L. B. Sadwin, T. Aversano, B. Brodie, P. K. O'Brien, R. Gray, L. F. Hiratzka, and D. Larson
Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: The Non-Percutaneous Coronary Intervention-Capable (ST-Elevation Myocardial Infarction Referral) Hospital Perspective
Circulation, July 10, 2007; 116(2): e49 - e54.
[Full Text] [PDF]


Home page
CMAJHome page
J. S. de Villiers, T. Anderson, J. D. McMeekin, R. C.M. Leung, M. Traboulsi, and for the Foothills Interventional Cardiology Servic
Expedited transfer for primary percutaneous coronary intervention: a program evaluation
Can. Med. Assoc. J., June 19, 2007; 176(13): 1833 - 1838.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
I. Popescu, M. S. Vaughan-Sarrazin, and G. E. Rosenthal
Differences in Mortality and Use of Revascularization in Black and White Patients With Acute MI Admitted to Hospitals With and Without Revascularization Services
JAMA, June 13, 2007; 297(22): 2489 - 2495.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. J. Lindsberg and H. P. Mattle
Response to Letter by Vatankhah et al
Stroke, June 1, 2007; 38(6): e30 - e30.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, C. Serantoni, M. Aquilina, S. Silenzi, F. Baldazzi, D. Grosseto, et al.
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction
Eur. Heart J., July 1, 2006; 27(13): 1550 - 1557.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
The American Heart Association's Acute Myocardial, A. K. Jacobs, E. M. Antman, G. Ellrodt, D. P. Faxon, T. Gregory, G. A. Mensah, P. Moyer, J. Ornato, E. D. Peterson, et al.
Recommendation to Develop Strategies to Increase the Number of ST-Segment-Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention
Circulation, May 2, 2006; 113(17): 2152 - 2163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. K. Jacobs
Regionalized Care for Patients With ST-Elevation Myocardial Infarction: It's Closer Than You Think
Circulation, March 7, 2006; 113(9): 1159 - 1161.
[Full Text] [PDF]


Home page
HeartHome page
J P S Henriques, F Zijlstra, A W J van 't Hof, M-J de Boer, J-H E Dambrink, A T M Gosselink, J C A Hoorntje, J P Ottervanger, and H Suryapranata
Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location
Heart, January 1, 2006; 92(1): 75 - 79.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. P. Wharton Jr, E. C. Keeley, C. L. Grines, T. P. Wharton Jr, E. C. Keeley, and C. L. Grines
The Case for Community Hospital Angioplasty
Circulation, November 29, 2005; 112(22): 3509 - 3534.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al.
Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Eur. Heart J., April 2, 2005; 26(8): 804 - 847.
[Full Text] [PDF]


Home page
CirculationHome page
H. C. Herrmann
Transfer for Primary Angioplasty: The Importance of Time
Circulation, February 15, 2005; 111(6): 718 - 720.
[Full Text] [PDF]


Home page
CirculationHome page
B. K. Nallamothu, E. R. Bates, J. Herrin, Y. Wang, E. H. Bradley, H. M. Krumholz, and for the NRMI Investigators
Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 Analysis
Circulation, February 15, 2005; 111(6): 761 - 767.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. E. Waters II, K. P. Singh, M. T. Roe, M. Lotfi, M. H. Sketch Jr, K. W. Mahaffey, L. K. Newby, J. H. Alexander, R. A. Harrington, R. M. Califf, et al.
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2153 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. W.J van't Hof, N. Ernst, M.-J. de Boer, R. de Winter, E. Boersma, T. Bunt, S. Petronio, A.T Marcel Gosselink, W. Jap, F. Hollak, et al.
Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial
Eur. Heart J., May 2, 2004; 25(10): 837 - 846.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. C Petrie and F. Zijlstra
Reflections on the Danish Revolution
Eur. Heart J., April 1, 2004; 25(7): 540 - 542.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. R. Chaitman
Efficacy and Safety of a Metabolic Modulator Drug in Chronic Stable Angina: Review of Evidence from Clinical Trials
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S47 - S64.
[Abstract] [PDF]


Home page
CirculationHome page
P. G. Steg, E. Bonnefoy, S. Chabaud, F. Lapostolle, P.-Y. Dubien, P. Cristofini, A. Leizorovicz, P. Touboul, and for the Comparison of Angioplasty and Prehospital
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial
Circulation, December 9, 2003; 108(23): 2851 - 2856.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Thimme
A critical amendment to the Meta-analysis of clinical trials comparing Thrombolysis with Primary Angioplasty
Eur. Heart J., October 2, 2003; 24(20): 1898 - 1898.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. Perez de Arenaza, A. K Taneja, and M. Flather
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction (PRAGUE-2 trial)
Eur. Heart J., October 1, 2003; 24(19): 1798 - 1798.
[Full Text] [PDF]


Home page
NEJMHome page
A. K. Jacobs
Primary Angioplasty for Acute Myocardial Infarction -- Is It Worth the Wait?
N. Engl. J. Med., August 21, 2003; 349(8): 798 - 800.
[Full Text] [PDF]